Follow The Filings

CHRW C.H. Robinson

Industrials, filed as C H ROBINSON WORLDWIDE INC (COM NEW), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Sold by 5 managers in 2026 Q2

  • 1 Owner
  • Max 0.4%
  • $1M

Who owns this now

Largest portfolio weights among holders, up to 0.4% (Murphy Pohlad, Murphy Pohlad Asset Management). Not free-float ownership.

  1. Murphy Pohlad 0.35%

Who owns CHRW

Sorted by value, long equity only, as of 2026 Q3.

History
Murphy Pohlad, Murphy Pohlad Asset Management 0.35% Hold 6,887 $1M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CHRW's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CHRW insider trades
  • $502K bought by 4 insiders
  • $16.1M sold by 2 insiders outside a trading plan
  • $2.8M sold by 3 insiders under 10b5-1 plans
  1. Michael D. Castagnetto Pres, NAST
    Buy
    $100K 594 shares at $168.24 +1.7% to stake
    Traded Feb 12 Filed Feb 13
    ↗
  2. David P Bozeman CEO
    Buy
    $200K 1,223 shares at $163.35 +0.6% to stake
    Traded Feb 12 Filed Feb 13
    ↗
  3. Arun Rajan Chief Strat & Innov Officer
    Buy
    $101K 605 shares at $167.11 +0.5% to stake
    Traded Feb 12 Filed Feb 13
    ↗
  4. Damon J. Lee CFO
    Buy
    $101K 620 shares at $162.52 +1.5% to stake
    Traded Feb 12 Filed Feb 13
    ↗
  5. Angela K. Freeman CHRO and ESG Officer
    Sale
    $1.7M 8,579 shares at $200.52 13% of stake
    Traded Feb 9 Filed Feb 11
    ↗
  6. Michael John Short President, Global Forwarding
    Planned sale
    $1.3M 6,368 shares at $201.30 11% of stake
    Traded Feb 9 Filed Feb 11
    ↗
  7. Michael D. Castagnetto Pres, NAST
    Planned sale
    $553K 2,849 shares at $194.20 9.2% of stake
    Traded Feb 2 Filed Feb 4
    ↗
  8. Michael John Short President, Global Forwarding
    Planned sale
    $215K 1,230 shares at $175.00 2.2% of stake
    Traded Jan 15 Filed Jan 20
    ↗
  9. Michael John Short President, Global Forwarding
    Planned sale
    $387K 2,390 shares at $161.91 4.2% of stake
    Traded Dec 31, 2025 Filed Jan 5
    ↗
  10. Arun Rajan Chief Strat & Innov Officer
    Planned sale
    $382K 2,500 shares at $152.77 1.9% of stake
    Traded Nov 17, 2025 Filed Nov 18, 2025
    ↗
  11. Angela K. Freeman CHRO and ESG Officer
    Sale
    $7.5M 49,884 shares at $149.71 43% of stake
    Traded Nov 6, 2025 Filed Nov 10, 2025
    ↗
  12. Michael D. Castagnetto Pres, NAST
    Sale
    $6.9M 45,266 shares at $151.70 57% of stake
    Traded Nov 3, 2025 Filed Nov 5, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 18 share withholdings for taxes, 13 stock grants, 7 option exercises, and 1 gift.

Congress

3 members of Congress traded CHRW in the last three years: 18 buys and 5 sales. 2 members listed it in 2025 annual reports.

All Congress trades
  1. April McClain Delaney D-MD-6Child Sell $100K–$250K Aug 25 filed Sep 9
  2. April McClain Delaney D-MD-6Child Buy $1K–$15K Aug 14 filed Sep 9
  3. April McClain Delaney D-MD-6Child Buy $1K–$15K Aug 12 filed Sep 9
  4. April McClain Delaney D-MD-6Child Buy $1K–$15K Aug 5 filed Sep 9
  5. April McClain Delaney D-MD-6Child Buy $15K–$50K Aug 3 filed Sep 9
  6. April McClain Delaney D-MD-6Child Buy $15K–$50K Jul 31 filed Aug 3

SEC filings

Recent issuer filings from EDGAR, 15 shown.

Filed Form Detail Links
8-K 1.01,2.02,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01 Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $17.6B $17.72B $16.23B
Net income $325.13M $465.69M $587.08M
Net margin * 1.8% 2.6% 3.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $2.88B $2.97B $2.8B
Total non-current assets * $2.34B $2.33B $2.26B
Total assets $5.23B $5.3B $5.06B
Total current liabilities $2.05B $2.32B $1.83B
Total non-current liabilities * $1.75B $1.25B $1.38B
Total equity $1.42B $1.72B $1.85B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $731.95M $509.08M $914.52M
Cash from investing -$82.79M -$74.29M -$54.67M
Cash from financing -$717.83M -$416.1M -$862.75M
Net change in cash -$71.96M $10.54M $4.33M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.